Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
Palliative Treatment of Patients With Multiple Myeloma and Painful Vertebral Lesions. A Cross-sectoral Randomized Controlled Trial of Vertebroplasty in Addition to Regular Medical Treatment.
Spine Centre of Southern Denmark
90 participants
Mar 29, 2021
INTERVENTIONAL
Conditions
Summary
Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).
Eligibility
Inclusion Criteria6
- known multiple myeloma
- verified lesion(s) between Th6-L5
- or less fractures
- relevant pain in 3 months or less
- vertebroplasty can be performed in one procedure
- VAS 5 or more
Exclusion Criteria2
- presence of neurologic deficit
- psychological or psychiatric disorder hat is expected to interfere with compliance
Interventions
Injection of cement into vertebral lesion(s)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04533217